Shares in Australian pharma Immuron are going nuts

Shares in pharmaceutical company Immuron Limited surged by 80% when it announced promising results in testing its anti-inflammation drug. The Australian microbiome is developing and commercialising treatments for inflammatory and infectious diseases.

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.